Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis
- PMID: 21606976
- DOI: 10.1038/ajg.2011.164
Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis
Abstract
Objectives: Chronic idiopathic constipation (CIC) is a common functional gastrointestinal disorder in the community, yet no previous systematic review and meta-analysis has estimated the global prevalence, or potential risk factors for the condition.
Methods: MEDLINE, EMBASE, and EMBASE Classic were searched (up to December 2010) to identify population-based studies reporting the prevalence of CIC in adults (≥15 years), according to self-report, questionnaire, or specific symptom-based criteria. The prevalence of CIC was extracted for all studies, and according to country, age, gender, socioeconomic status, and presence or absence of irritable bowel syndrome (IBS) where reported. Pooled prevalence overall, and according to study location and certain other characteristics, as well as odds ratios (ORs), with 95% confidence intervals (CIs) were calculated.
Results: Of the 100 papers evaluated, 45 reported the prevalence of CIC in 41 separate study populations, containing 261,040 subjects. Pooled prevalence of CIC in all studies was 14% (95% CI: 12-17%). The prevalence of CIC was lower in South East Asian studies, and in studies using the Rome II or III criteria. The prevalence of CIC was higher in women (OR: 2.22; 95% CI: 1.87-2.62), and increased with age and lower socioeconomic status. The prevalence was markedly higher in subjects who also reported IBS (OR: 7.98; 95% CI: 4.58-13.92), suggesting common pathogenic mechanisms.
Conclusions: Pooled prevalence of CIC in the community was 14%, and of similar magnitude in most geographical regions. Rates were higher in women, older individuals, and those of lower socioeconomic status. Presence of IBS was strongly associated with CIC.
Similar articles
-
Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis.Clin Gastroenterol Hepatol. 2012 Jul;10(7):712-721.e4. doi: 10.1016/j.cgh.2012.02.029. Epub 2012 Mar 15. Clin Gastroenterol Hepatol. 2012. PMID: 22426087
-
Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis.Am J Gastroenterol. 2012 Jul;107(7):991-1000. doi: 10.1038/ajg.2012.131. Epub 2012 May 22. Am J Gastroenterol. 2012. PMID: 22613905 Review.
-
Comorbidities in patients with irritable bowel syndrome with constipation or chronic idiopathic constipation: a review of the literature from the past decade.Postgrad Med. 2013 Mar;125(2):40-50. doi: 10.3810/pgm.2013.03.2640. Postgrad Med. 2013. PMID: 23816770 Review.
-
The spectrum of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation: US survey assessing symptoms, care seeking, and disease burden.Am J Gastroenterol. 2015 Apr;110(4):580-7. doi: 10.1038/ajg.2015.67. Epub 2015 Mar 17. Am J Gastroenterol. 2015. PMID: 25781368 Free PMC article.
-
Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2021 Aug;6(8):638-648. doi: 10.1016/S2468-1253(21)00111-4. Epub 2021 Jun 4. Lancet Gastroenterol Hepatol. 2021. PMID: 34090581
Cited by
-
Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders.Aliment Pharmacol Ther. 2021 Jun;53(12):1250-1267. doi: 10.1111/apt.16369. Epub 2021 Apr 28. Aliment Pharmacol Ther. 2021. PMID: 33909919 Free PMC article. Review.
-
Lack of familial aggregation in chronic constipation excluding irritable bowel syndrome: a population-based study.Dig Dis Sci. 2015 May;60(5):1358-65. doi: 10.1007/s10620-014-3475-x. Epub 2014 Dec 23. Dig Dis Sci. 2015. PMID: 25532498 Free PMC article.
-
Lactobacillus rhamnosus GG normalizes gut dysmotility induced by environmental pollutants via affecting serotonin level in zebrafish larvae.World J Microbiol Biotechnol. 2022 Sep 14;38(12):222. doi: 10.1007/s11274-022-03409-y. World J Microbiol Biotechnol. 2022. PMID: 36100774
-
Comparative efficacy and safety of lactulose plus paraffin vs polyethylene glycol in functional constipation: a randomised clinical study.United European Gastroenterol J. 2020 Oct;8(8):923-932. doi: 10.1177/2050640620937913. Epub 2020 Jun 28. United European Gastroenterol J. 2020. PMID: 32594884 Free PMC article. Clinical Trial.
-
Prevalence and associated factors of chronic constipation among Japanese university students.Front Public Health. 2024 Jan 16;12:1258020. doi: 10.3389/fpubh.2024.1258020. eCollection 2024. Front Public Health. 2024. PMID: 38292906 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous